Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharmaust Limited (DE:ECQ)
FRANKFURT:ECQ
RESEARCH TOOLSreports
Pharmaust Limited (ECQ) Stock Price & Analysis
0 Followers
ECQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.03 - €0.25
Previous Close€0.1
Volume0.00
Average Volume (3M)N/A
Market Cap
€58.88M
Enterprise Value€58.24M
Total Cash (Recent Filing)AU$2.42M
Total Debt (Recent Filing)AU$1.39M
Price to Earnings (P/E)―
Beta1.54
Next Earnings
Aug 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding395,013,669
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pharmaust Limited News
PremiumCompany Announcements
PharmAust Limited Joins HEALEY ALS Trial
PremiumCompany Announcements
PharmAust’s Monepantel Advances in ALS Trial
PremiumCompany Announcements
PharmAust Limited Plans Investor Sessions on Clinical Study
PremiumCompany Announcements
PharmAust Limited Eyes Growth in Neurodegenerative MarketPremiumCompany Announcements
Pharmaust Limited Issues 5M Unlisted OptionsPremiumCompany Announcements
Pharmaust Limited Boosts Investor Relations
PremiumCompany Announcements
Pharmaust Limited Applies for New Securities Quotation
PremiumCompany Announcements
PharmAust Launches Share Purchase PlanECQ FAQ
What was Pharmaust Limited’s price range in the past 12 months?
Pharmaust Limited lowest stock price was €0.03 and its highest was €0.25 in the past 12 months.
What is Pharmaust Limited’s market cap?
Currently, no data Available
When is Pharmaust Limited’s upcoming earnings report date?
Pharmaust Limited’s upcoming earnings report date is Aug 30, 2024 which is in 42 days.
How were Pharmaust Limited’s earnings last quarter?
Pharmaust Limited released its earnings results on Feb 29, 2024. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is Pharmaust Limited overvalued?
According to Wall Street analysts Pharmaust Limited’s price is currently Overvalued.
Does Pharmaust Limited pay dividends?
Pharmaust Limited does not currently pay dividends.
What is Pharmaust Limited’s EPS estimate?
Pharmaust Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmaust Limited have?
Currently, no data Available
What happened to Pharmaust Limited’s price movement after its last earnings report?
Pharmaust Limited reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.556%.
Which hedge fund is a major shareholder of Pharmaust Limited?
Currently, no hedge funds are holding shares in DE:ECQ
---
Pharmaust Limited Stock Smart Score
Company Description
Pharmaust Limited
PharmAust Ltd operates as a drug discovery and development company in Australia, Switzerland, and internationally. It develops drug discovery intellectual property for the treatment of various cancers in humans and animals. The company offers Monepantel and Albendazole, which are in Phase II clinical trials for the treatment of cancer. It also provides medicinal and synthetic chemistry services on a contract basis to the drug discovery and pharmaceutical industries.
---
Technical Analysis
Mister Spex SE
―
Bod Australia Ltd
―
IDT Australia Limited
―
Medical Developments International Limited
―
---